These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 12117687)

  • 1. Patients with systemic lupus erythematosus show a normal responsive search score in exploratory eye movement analysis: comparison with schizophrenia.
    Matsukawa Y; Takahashi S; Aoki M; Yamakami K; Nishinarita S; Horie T; Fukura Y; Tanabe E; Yara K; Matsuura M; Kojima T
    Ann Rheum Dis; 2002 Aug; 61(8):748-50. PubMed ID: 12117687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eye movement and random number in NP lupus evaluation.
    Matsukawa Y; Kamei S; Takahashi S; Kojima T; Nagashima M; Matsuura M; Sawada S
    Clin Rheumatol; 2008 Feb; 27(2):237-40. PubMed ID: 17972009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of exploratory eye movement in a patient with lupus psychosis.
    Matsukawa Y; Son K; Nishinarita S; Horie T; Tanabe E; Takahashi S; Tanabe Y; Matsuura M; Kojima T
    Clin Rheumatol; 1998; 17(5):383-6. PubMed ID: 9805182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Eye movements in schizophrenia--relationships among eye movements under three experimental conditions; closed-eye, pursuit, and exploratory].
    Nakajima K
    Seishin Shinkeigaku Zasshi; 1990; 92(8):509-31. PubMed ID: 2236349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploratory eye movements and neuropsychological tests in schizophrenic patients.
    Kojima T; Matsushima E; Ando K; Ando H; Sakurada M; Ohta K; Moriya H; Shimazono Y
    Schizophr Bull; 1992; 18(1):85-94. PubMed ID: 1553506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of exploratory eye movements as a marker of schizophrenia--a WHO multi-center study. World Health Organization.
    Kojima T; Matsushima E; Ohta K; Toru M; Han YH; Shen YC; Moussaoui D; David I; Sato K; Yamashita I; Kathmann N; Hippius H; Thavundayil JX; Lal S; Vasavan Nair NP; Potkin SG; Prilipko L
    Schizophr Res; 2001 Dec; 52(3):203-13. PubMed ID: 11705714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between exploratory eye movement, P300, and reaction time in schizophrenia.
    Takahashi S; Tanabe E; Sakai T; Matsuura M; Matsushima E; Obayashi S; Kojima T
    Psychiatry Clin Neurosci; 2008 Aug; 62(4):396-403. PubMed ID: 18778436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploratory eye movement dysfunction as a discriminator for schizophrenia : a large sample study using a newly developed digital computerized system.
    Suzuki M; Takahashi S; Matsushima E; Tsunoda M; Kurachi M; Okada T; Hayashi T; Ishii Y; Morita K; Maeda H; Katayama S; Kawahara R; Otsuka T; Hirayasu Y; Sekine M; Okubo Y; Motoshita M; Ohta K; Uchiyama M; Kojima T
    Eur Arch Psychiatry Clin Neurosci; 2009 Apr; 259(3):186-94. PubMed ID: 19165524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Random number generation evaluation in patients with systemic lupus erythematosus indicates a heterogeneous nature of central nervous system vulnerability.
    Matsukawa Y; Nagashima M; Kamei S; Tanabe E; Takahashi S; Kojima T; Taira M; Morita K; Matsuura M; Sawada S
    Scand J Rheumatol; 2006; 35(4):295-9. PubMed ID: 16882594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired exploratory eye movements in children with Asperger's syndrome.
    Ohya T; Morita K; Yamashita Y; Egami C; Ishii Y; Nagamitsu S; Matsuishi T
    Brain Dev; 2014 Mar; 36(3):241-7. PubMed ID: 23668935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impairment of exploratory eye movement in schizophrenia patients and their siblings.
    Takahashi S; Tanabe E; Yara K; Matsuura M; Matsushima E; Kojima T
    Psychiatry Clin Neurosci; 2008 Oct; 62(5):487-93. PubMed ID: 18950366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploratory eye movements in schizophrenic patients and patients with frontal lobe lesions.
    Matsushima E; Kojima T; Ohbayashi S; Ando H; Ando K; Shimazono Y
    Eur Arch Psychiatry Clin Neurosci; 1992; 241(4):210-4. PubMed ID: 1576176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of reversible axonal dysfunction in systemic lupus erythematosus: a proton MRS study.
    Appenzeller S; Li LM; Costallat LT; Cendes F
    Brain; 2005 Dec; 128(Pt 12):2933-40. PubMed ID: 16195241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic lupus erythematosus in Spanish males: a study of the Spanish Rheumatology Society Lupus Registry (RELESSER) cohort.
    Riveros Frutos A; Casas I; Rúa-Figueroa I; López-Longo FJ; Calvo-Alén J; Galindo M; Fernández-Nebro A; Pego-Reigosa JM; Olivé Marqués A;
    Lupus; 2017 Jun; 26(7):698-706. PubMed ID: 27799439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychiatric and psychosocial disorders in patients with systemic lupus erythematosus: a longitudinal study of active and inactive stages of the disease.
    Seguí J; Ramos-Casals M; García-Carrasco M; de Flores T; Cervera R; Valdés M; Font J; Ingelmo M
    Lupus; 2000; 9(8):584-8. PubMed ID: 11035432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The chronic damage in systemic lupus erythematosus is driven by flares, glucocorticoids and antiphospholipid antibodies: results from a monocentric cohort.
    Conti F; Ceccarelli F; Perricone C; Leccese I; Massaro L; Pacucci VA; Truglia S; Miranda F; Spinelli FR; Alessandri C; Valesini G
    Lupus; 2016 Jun; 25(7):719-26. PubMed ID: 26821965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cognitive dysfunction in schizophrenia--analysis using exploratory eye movements].
    Kojima T; Matsushima E
    Seishin Shinkeigaku Zasshi; 2000; 102(5):445-58. PubMed ID: 10897677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.
    İlgen U; Yayla ME; Ateş A; Okatan İE; Yurteri EU; Torgutalp M; Keleşoğlu ABD; Turgay TM; Kınıklı G
    Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced Aerobic Capacity and Quality of Life in Physically Inactive Patients With Systemic Lupus Erythematosus With Mild or Inactive Disease.
    Pinto AJ; Miyake CN; Benatti FB; Silva CA; Sallum AM; Borba E; de Sá-Pinto AL; Bonfá E; Gualano B
    Arthritis Care Res (Hoboken); 2016 Dec; 68(12):1780-1786. PubMed ID: 27058995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the quality, reliability and readability of online health information regarding systemic lupus erythematosus.
    Reynolds M; Hoi A; Buchanan RRC
    Lupus; 2018 Oct; 27(12):1911-1917. PubMed ID: 30114969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.